A detailed history of N Verses Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, N Verses Capital, LLC holds 900 shares of AMGN stock, worth $260,909. This represents 0.13% of its overall portfolio holdings.

Number of Shares
900
Previous 100 800.0%
Holding current value
$260,909
Previous $31.2 Million 828.11%
% of portfolio
0.13%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

BUY
$309.38 - $337.38 $247,504 - $269,904
800 Added 800.0%
900 $290 Million
Q2 2024

Jul 31, 2024

BUY
$262.75 - $319.31 $26,275 - $31,931
100 New
100 $31.2 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track N Verses Capital, LLC Portfolio

Follow N Verses Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of N Verses Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on N Verses Capital, LLC with notifications on news.